- Report
- August 2023
- 293 Pages
Global
From €3383EUR$3,570USD£2,855GBP
- Report
- July 2023
- 382 Pages
Global
From €3383EUR$3,570USD£2,855GBP
- Report
- February 2023
- 300 Pages
Global
From €3383EUR$3,570USD£2,855GBP
- Report
- June 2021
- 245 Pages
Global
From €3517EUR$3,712USD£2,968GBP
- Report
- July 2024
- 233 Pages
Global
From €2516EUR$2,655USD£2,123GBP
- Report
- April 2023
- 252 Pages
Global
From €3383EUR$3,570USD£2,855GBP
- Report
- May 2022
- 256 Pages
Global
From €3275EUR$3,456USD£2,764GBP
- Book
- March 2024
- 496 Pages
- Book
- June 2022
- 496 Pages
- Book
- November 2019
- 368 Pages
- Book
- June 2019
- 304 Pages
- Book
- June 2019
- 496 Pages
- Book
- April 2018
- 312 Pages
- Book
- January 2016
- 472 Pages
- Book
- January 2015
- 600 Pages
- Book
- October 2009
- 912 Pages
- Book
- March 2022
- 896 Pages
- Book
- September 2021
- 432 Pages
- Book
- February 2021
- 544 Pages

The Antibody Drug market is a subset of the biotechnology industry that focuses on the development and commercialization of therapeutic antibodies. Antibody drugs are used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. These drugs are designed to target specific molecules in the body, such as proteins, hormones, and enzymes, and can be used to block or activate certain pathways. Antibody drugs are typically administered intravenously or subcutaneously, and can be used in combination with other drugs or therapies.
The Antibody Drug market is highly competitive, with many companies investing in research and development to create new and improved treatments. Companies in the market are focused on developing novel antibodies, as well as improving existing treatments. Additionally, companies are investing in the development of biosimilars, which are generic versions of existing antibody drugs.
Some companies in the Antibody Drug market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, Regeneron, Roche, and Sanofi. Show Less Read more